SEC Filings - Marker Therapeutics, Inc.

Filing date	Form	Description	View
Mar 16, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001144204-15-016463.pdf 0001144204-15-016463.rtf 0001144204-15-016463.xls View HTML
Feb 14, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001193125-19-040985.pdf 0001193125-19-040985.rtf 0001193125-19-040985.xls View HTML
May 15, 2018	DEFA14A	Additional proxy soliciting materials - definitive	0001144204-18-028371.pdf 0001144204-18-028371.rtf 0001144204-18-028371.xls View HTML
Aug 8, 2018	DEFA14A	Additional proxy soliciting materials - definitive	0001144204-18-042863.pdf 0001144204-18-042863.rtf 0001144204-18-042863.xls View HTML
Mar 28, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001144204-19-016699.pdf 0001144204-19-016699.rtf 0001144204-19-016699.xls View HTML
Apr 23, 2021	DEFA14A	Additional proxy soliciting materials - definitive	0001104659-21-054487.pdf 0001104659-21-054487.rtf View HTML
Mar 26, 2004	DEFA14A	Additional proxy soliciting materials - definitive	0001092306-04-000175.pdf 0001092306-04-000175.rtf View HTML
Apr 17, 2014	10-K/A	Amendment to a previously filed 10-K	0001424884-14-000048.pdf 0001424884-14-000048.rtf 0001424884-14-000048.xls EX-101.INS - View HTML
Aug 19, 2013	10-Q/A	Amendment to a previously filed 10-Q	0001424884-13-000037.pdf 0001424884-13-000037.rtf 0001424884-13-000037.xls EX-101.INS - View HTML
May 21, 2014	10-Q/A	Amendment to a previously filed 10-Q	0001424884-14-000063.pdf 0001424884-14-000063.rtf 0001424884-14-000063.xls EX-101.INS - View HTML

Data provided by Kaleidoscope.